Karius
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
975 Island Dr Ste 101, Redwood City, Cal...Phone Number
(866) 452-7487Website
www.kariusdx.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
3
1
1
About Karius
Founded in 2014 and headquartered in Redwood City, California, Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions.Explore more
Karius Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Karius your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Karius, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Karius recently announced quarterly report
Check if Karius has recently received funding, and reach out quickly before it becomes old news!
Click to see if Karius had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Karius launches new products
Check out if Karius is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Karius
Funding: Get notified immidiatlly once Karius has new funding data
Recommended Actions
Find VP level buyers at Karius
Find 3 more new buyers
Compare Similar Companies to Karius
Compare insights from companies similar to Karius, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Karius
$10.6M
51-200
Private
$320M
2014
NK
Nipum KumarHealth Systems Vice President, Commercial Strategy
Company Profile Activity
Activity Insights
Karius is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Karius is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Karius.
Karius financials insights
Gather financial insights about Karius, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Other Financing Round
$5M
2017
Series A
$50M
2020
Unspecified
$165M
2024
Series C
$100M
Karius Tech Stack
A closer look at the technologies used by Karius
Most Recent Scoops
Open Position
Person-Based
Partnership, Medical Research
Open Position
Open Position
Open Position
Karius News & Media
Karius Secures BARDA Contract to Expand Agnostic Detection of Pathogens
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Karius®, Inc. today announced it has been awarded a contract from the Division of Research, Innovation, and Ventures (DRIVe), under the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services. Valued over $600,000, the contract enables Karius to extend its current DNA pathogen detection capabilities to include RNA pathogen deteKarius Test® Receives FDA Breakthrough Device Designation to Aid in the Diagnosis of Infectious Disease
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Karius®, Inc., a leader in genomic diagnostics for infectious diseases, announced today that the Karius Test® has been granted designation as a Breakthrough Device from The Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA), for use in the diagnosis and management of immunocompromised patients with suspected lung infections including lower respiratory infection and pneumonia. “The Karius Test is commercially avaiWilson Sonsini Advises Karius on IP Matters Related to $100 Million Series C
On May 2, 2024, Karius®, Inc. (Karius), a world leader in genomic diagnostics for infectious disease, announced the successful completion of a $100 million Series C financing. Khosla Ventures, along with new investors 5AM Ventures and Gilde Healthcare, co-led the round. New investor Seventure Partners, and existing investors Softbank Vision Fund 2, General Catalyst, HBM Healthcare Investments,…Karius raises $100M to expand access to multi-pathogen blood test | MedTech Dive
Karius plans to use the funding to expand the test outside of the hospital setting and support research of the company’s DNA technology beyond infectious diseases.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Karius
Sign Up For FreeTo access detailed company insights
Founded in 2014 and headquartered in Redwood City, California, Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions.... Read More
